Related Articles
REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells
Increased MALAT1 expression contributes to cisplatin resistance in non‑small cell lung cancer
Hypersensitivity to cisplatin after hRev3 mRNA knockdown in head and neck squamous cell carcinoma cells
Upregulation of miR‑146a increases cisplatin sensitivity of the non‑small cell lung cancer A549 cell line by targeting JNK‑2
Impaired ζ chain expression and IFN-γ production in peripheral blood T and NK cells of patients with advanced lung cancer